|
US5208036A
(en)
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
WO1994012629A1
(en)
|
1992-12-02 |
1994-06-09 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
AU698962B2
(en)
|
1993-09-14 |
1998-11-12 |
Epimmune, Inc. |
Alteration of immune response using pan DR-binding peptides
|
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
US5840838A
(en)
|
1996-02-29 |
1998-11-24 |
University Of Kentucky Research Foundation |
Process for enhancing the activity of amyloid β peptides
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US7264810B2
(en)
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
US6906169B2
(en)
*
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
|
WO2004087733A2
(en)
|
2003-03-28 |
2004-10-14 |
New York University |
Prevention and treatment of alzheimer amyloid deposition
|
|
CA2657953A1
(en)
|
2005-07-19 |
2007-01-25 |
University Of Rochester |
Alpha-synuclein antibodies and methods related thereto
|
|
WO2007103770A2
(en)
*
|
2006-03-02 |
2007-09-13 |
Ppd Biomarker Discovery Sciences, Llc |
Compositions and methods for analyzing renal cancer
|
|
KR20120017469A
(ko)
|
2007-01-05 |
2012-02-28 |
유니버시티 오브 취리히 |
질환 특이적 결합 분자 및 표적을 제공하는 방법
|
|
ATE524487T1
(de)
*
|
2007-01-11 |
2011-09-15 |
Univ Ramot |
Tau peptidmimetikum zur behandlung von neurodegenerativen erkrankungen
|
|
AT506819B1
(de)
|
2008-06-12 |
2011-06-15 |
Affiris Forschungs Und Entwicklungs Gmbh |
Vakzin zur behandlung von alzheimer-krankheit
|
|
CA3239368A1
(en)
*
|
2009-06-10 |
2010-12-16 |
New York University |
Immunological targeting of pathological tau proteins
|
|
EP2382993A1
(en)
*
|
2010-04-19 |
2011-11-02 |
KTB Tumorforschungsgesellschaft mbH |
Combination of drugs with protein-binding prodrugs
|
|
ES2656442T3
(es)
*
|
2011-09-19 |
2018-02-27 |
Axon Neuroscience Se |
Terapia basada en proteínas y diagnóstico de una patología mediada por tau en la enfermedad de Alzheimer
|
|
US9738709B2
(en)
*
|
2011-10-21 |
2017-08-22 |
Ohio State Innovation Foundation |
Methylated peptides derived from tau protein and their antibodies for diagnosis and therapy of alzheimer's disease
|
|
CA2885924C
(en)
*
|
2012-08-21 |
2022-12-13 |
Institute For Molecular Medicine, Inc. |
Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein
|
|
US20170368167A9
(en)
*
|
2012-08-21 |
2017-12-28 |
The Institute For Molecular Medicine |
Compositions and methods related to neurological disorders
|
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
|
CA2902026C
(en)
|
2013-03-13 |
2023-08-29 |
Prothena Biosciences Limited |
Tau immunotherapy
|
|
WO2015165961A1
(en)
|
2014-04-29 |
2015-11-05 |
Affiris Ag |
Treatment and prevention of alzheimer's disease (ad)
|
|
CA3003483C
(en)
|
2015-11-06 |
2022-09-13 |
Adjuvance Technologies, Inc. |
Triterpene saponin analogues
|
|
EP3452507B1
(en)
|
2016-05-02 |
2022-10-19 |
Prothena Biosciences Limited |
Tau immunotherapy
|
|
CA3022515A1
(en)
|
2016-05-02 |
2017-11-09 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
PE20190208A1
(es)
|
2016-05-02 |
2019-02-07 |
Prothena Biosciences Ltd |
Anticuerpos que reconocen tau
|
|
CN110506057B
(zh)
|
2017-02-17 |
2023-09-29 |
百时美施贵宝公司 |
Alpha突触核蛋白抗体及其应用
|
|
EP3609505A4
(en)
|
2017-04-13 |
2021-04-28 |
Adjuvance Technologies, Inc. |
TRITERPEN-SAPONIN SYNTHESIS, INTERMEDIATES AND COMBINATIONS OF ADJUVANCES
|
|
CN110730666A
(zh)
|
2017-04-25 |
2020-01-24 |
佐剂技术公司 |
三萜皂苷类似物
|
|
CN110881274B
(zh)
|
2017-05-02 |
2024-11-15 |
普罗塞纳生物科学有限公司 |
识别tau的抗体
|
|
BR112019026707A2
(pt)
|
2017-06-16 |
2020-06-30 |
United Neuroscience |
imunógenos de peptídeo da extremidade c-terminal da proteína alfa-sinucleína e formulações dos mesmos para o tratamento de sinucleinopatias
|
|
WO2019070480A1
(en)
|
2017-10-02 |
2019-04-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
ASSAY FOR DETECTION OF ALPHA-SYNUCLEIN SELF-ACTIVATION ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES
|
|
WO2019070813A2
(en)
*
|
2017-10-03 |
2019-04-11 |
The Trustees Of Columbia University In The City Of New York |
USE OF PEPTIDES AS BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION AND TREATMENT OF A NEUROLOGICAL DISORDER
|
|
WO2019079160A1
(en)
|
2017-10-16 |
2019-04-25 |
Adjuvance Technologies, Inc. |
TRITERPENIC SAPONIN ANALOGS
|
|
KR20230080397A
(ko)
*
|
2020-08-07 |
2023-06-07 |
오타이르 프로테나 리미티드 |
알츠하이머 질환을 치료하기 위한 멀티에피토프 백신
|